Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The footer and the about page refer only to state-licensed 503A and 503B compounding pharmacies, and the terms to pharmacies in general. 2 more criteria also fail; see the table below.
At a glance
Fresh Day MedsTelehealth service
5/8criteria passed
Price
Semaglutide from $99 a month on a 3-month plan, tirzepatide from $140
Sells
compounded semaglutide, compounded tirzepatide, NAD+ injections, and 6 more
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A telehealth platform selling compounded semaglutide and tirzepatide vials on one-month and three-month subscriptions at one price for every dose, plus NAD+ and MIC+B12 injections and tablets for sexual health, hair and testosterone. Care starts with an online assessment, and it names no pharmacy and prints no mailing address.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed provider reviews each assessment and decides whether treatment is appropriate, and the terms name Telegra MD as the medical group whose providers give care.Source: Fresh Day Meds' semaglutide page; Fresh Day Meds' terms of service page.
S2PASSThe qualify button opens an assessment that asks about the buyer and a health screen before the plan and payment steps, and the payment policy says the card is only held and is charged only if a provider approves.Source: Fresh Day Meds' semaglutide page; Fresh Day Meds' payment refund policy.
S3FAILNo filling pharmacy is named. The footer and the about page refer only to state-licensed 503A and 503B compounding pharmacies, and the terms to pharmacies in general.Source: Fresh Day Meds' website; Fresh Day Meds' about page; Fresh Day Meds' terms of service page.
S4PASSEach GLP-1 page states that the compounded drug is not FDA-approved, and the footer of every page says compounded medications are not FDA-approved and the FDA does not verify their safety, effectiveness or quality.Source: Fresh Day Meds' semaglutide page; Fresh Day Meds' tirzepatide page; Fresh Day Meds' website.
S5FAILNo certificate of analysis or lot document is published on the product pages, the about page, the answers page or the policies.Source: Fresh Day Meds' about page; Fresh Day Meds' FAQ.
S6FAILThe privacy policy states that Fresh Day Meds, LLC does not maintain a public-facing physical mailing address, and no address for the company is printed in the footer, on the contact page or in the terms. The terms print only the medical group's address in Spokane, Washington.Source: Fresh Day Meds' privacy policy; Fresh Day Meds' contact page; Fresh Day Meds' terms of service page.
S7PASSCompounded semaglutide at $99 a month on a 3-month plan for patients new to the drug, renewing at $299 a quarter, $128 a month on the 3-month transfer plan, renewing at $385, and $140 on a 1-month plan. Compounded tirzepatide at $140 a month on a 3-month plan, renewing at $420 a quarter, $156 on the 3-month transfer plan, renewing at $469, and $179 on a 1-month plan. NAD+ at $159 a month on a 3-month plan or $199 month to month, MIC+B12 at $119 or $149, tadalafil from $70, finasteride from $40 and enclomiphene from $149 a month. The price stays the same as the dose rises.Source: Fresh Day Meds' semaglutide page; Fresh Day Meds' tirzepatide page; Fresh Day Meds' NAD+ page; Fresh Day Meds' MIC B12 page; Fresh Day Meds' website.
S8PASSNo FDA warning letter names Fresh Day Meds or Fresh Day Meds, LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+ injections, MIC+B12 injections, tadalafil, sildenafil, finasteride, minoxidil, enclomiphene.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.